Cardio Diagnostics Holdings Inc
CDIO0.185USD
-0.027-12.85%
Close 05/09, 16:00（ET）Quotes delayed by 15 min
8.50MMarket Cap
LossP/E TTM
More Details of Cardio Diagnostics Holdings Inc Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Company Info
Company codeCDIO
Company nameCardio Diagnostics Holdings Inc
IPO dateNov 23, 2021
Founded at2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Number of employees13
Security typeOrdinary Share
Fiscal year-endNov 23
Address311 W. Superior Street
CityCHICAGO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code60645
Phone18552269991
Website
Company codeCDIO
IPO dateNov 23, 2021
Founded at2021
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Fri, May 9
Update time: Fri, May 9
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Shareholder Statistics
Shareholder
Proportion
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Type
Shareholder
Proportion
Individual Investor
4.22%
Corporation
3.04%
Investment Advisor
2.69%
Investment Advisor/Hedge Fund
1.36%
Hedge Fund
0.62%
Research Firm
0.22%
Venture Capital
0.11%
Other
87.74%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
43
6.55M
12.55%
+595.10K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
2022Q4
55
3.79M
39.83%
-7.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dogan (Meeshanthini)
1.66M
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
1.59M
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
2.05%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
364.39K
0.7%
+179.98K
+97.60%
Dec 31, 2024
Millennium Management LLC
256.94K
0.49%
+256.94K
--
Dec 31, 2024
The Vanguard Group, Inc.
232.14K
0.45%
--
--
Dec 31, 2024
HRT Financial LP
155.39K
0.3%
+144.38K
+1.31K%
Dec 31, 2024
Dogan (Timur)
128.34K
0.25%
-68.97K
-34.95%
Mar 20, 2025
Hosseinion (Warren)
116.05K
0.22%
--
--
Mar 20, 2025
Jane Street Capital, L.L.C.
112.56K
0.22%
+112.56K
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data